Glaukos (GKOS) EPS (Weighted Average and Diluted) Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -19.74% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.20% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.88% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 100.00% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 8.20% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 88.89% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.89% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 47.37% |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn | -6.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.25% |
| Dec 31, 2025 | -294.92% |
| Sep 30, 2025 | 28.21% |
| Jun 30, 2025 | 66.00% |
| Mar 31, 2025 | 60.98% |
| Dec 31, 2024 | 21.33% |
| Sep 30, 2024 | 38.10% |
| Jun 30, 2024 | -47.06% |
| Mar 31, 2024 | -13.89% |
| Dec 31, 2023 | -13.64% |
| Sep 30, 2023 | -8.62% |
| Jun 30, 2023 | 29.17% |
| Mar 31, 2023 | -754.55% |
| Dec 31, 2022 | -240.43% |
| Sep 30, 2022 | -546.15% |
| Jun 30, 2022 | -152.63% |
| Mar 31, 2022 | 130.56% |
| Dec 31, 2021 | 295.83% |
| Sep 30, 2021 | 137.14% |
| Jun 30, 2021 | 57.78% |
| Mar 31, 2021 | 70.97% |
| Dec 31, 2020 | -128.57% |
| Sep 30, 2020 | 5.41% |
| Jun 30, 2020 | -429.41% |
| Mar 31, 2020 | -3,000.00% |
| Dec 31, 2019 | 2,000.00% |
| Sep 30, 2019 | -94.74% |
| Jun 30, 2019 | -13.33% |
| Mar 31, 2019 | 50.00% |
| Dec 31, 2018 | 33.33% |
| Sep 30, 2018 | -575.00% |
| Jun 30, 2018 | -50.00% |
| Mar 31, 2018 | -500.00% |
| Dec 31, 2017 | -85.95% |
| Sep 30, 2017 | 33.33% |
| Jun 30, 2017 | -266.67% |
| Mar 31, 2017 | -33.33% |
| Dec 31, 2016 | 404.96% |
| Sep 30, 2016 | 142.86% |
| Jun 30, 2016 | 100.55% |
| Mar 31, 2016 | 107.50% |
| Dec 31, 2015 | 96.45% |
| Sep 30, 2015 | 89.06% |